Charles River Laboratories | CRL - Ordinary Share Capital



Charles River Laboratories reported $49.21M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Agilent USD 283.59M 280.59M Jul/2025
Align Technology USD 72.48M 572K Jun/2025
Bio-Rad Laboratories USD 27.06M 27.06M Jun/2025
Bruker USD 151.72M 149.92M Jun/2025
Cardinal Health USD 239M 2.71B Jun/2025
Charles River Laboratories USD 49.21M 48.7M Jun/2025
Cigna USD 266.6M 262.6M Jun/2025
CVS Health USD 1.27B 48.57B Jun/2025
Danaher USD 715.9M 706.9M Jun/2025
Dentsply International USD 199.3M 196.3M Jun/2025
Elevance Health USD 225.94M 223.94M Jun/2025
Galapagos EUR 65.9M 228.04M Jun/2025
Hologic USD 222.22M 219.22M Jun/2025
Humana USD 120.27M 87.27M Jun/2025
Illumina USD 154M 152M Jun/2025
Incyte USD 194.12M 193.93M Jun/2025
IQVIA Holdings USD 170M 167.42M Jun/2025
Laboratory Of America USD 82.9M 75.3M Jun/2025
Lonza CHF 72M 0 Dec/2024
McKesson USD 280M 277M Jun/2025
Merck EUR 434.78M 130.22M Jun/2025
Mettler Toledo International USD 20.6M 20.15M Jun/2025
Novartis USD 793M 0 Dec/2024
Pfizer USD 5.68B 5.2B Jun/2025
Quest Diagnostics USD 112M 110M Jun/2025
Revvity USD 117.87M 2.78M Jun/2025
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
United Therapeutics USD 45.22M 44.42M Jun/2025
UnitedHealth USD 907.14M 2.86M Jun/2025
Waters USD 59.51M 57.88M Jun/2025
West Pharmaceutical Services USD 71.9M 53.1M Jun/2025